OverviewChartProfileKey statisticsFinancialsNewsTraderScreen

Schroders PLC/  GB00BP9LHF23  /

Cboe Europe BXE
2024-04-16  11:53:32 AM Chg. -8.50 Volume Bid11:57:53 AM Ask11:57:54 AM Market Capitalization Dividend Y. P/E Ratio
366.60GBX -2.27% 24,937
Turnover(GBP): 91,369.3990		 366.20Bid Size: 200 366.80Ask Size: 596 5.77 mill.GBP - -
GlobeNewswire 04-10 Questex’s IHIF EMEA 2024: The Meeting Place of Hospitality Innovators and Game-Changers
GlobeNewswire 04-02 New York UNCF 80th Anniversary “A Mind Is…”® Gala Raises Nearly $950,000 for HBCUs and Students
GlobeNewswire 03-12 Azafaros announces completion of 12-week Phase 2 RAINBOW study evaluating lead asset nizubaglustat i...
GlobeNewswire 03-06 FE International Appoints Chris Mayo to Chair New Advisory Board
TeleTrader 03-04 Europe opens mixed after CPI readings
TeleTrader 03-01 Europe opens higher amid data
GlobeNewswire 02-28 “A Mind Is…”® New York Gala to Celebrate UNCF’s 80th Anniversary
GlobeNewswire 02-08 Neurona Therapeutics Raises $120M to Advance Groundbreaking Pipeline of Regenerative Cell Therapy Ca...
GlobeNewswire 01-23 Azafaros to present data from PRONTO study in patients with GM1 and GM2 gangliosidoses at the 20th a...
GlobeNewswire 2023-12-11 Azafaros’ Phase 2 RAINBOW study, evaluating nizubaglustat in GM2 and NPC patients, is now fully enr...
GlobeNewswire 2023-09-13 Investcorp-Tages Partnering with Engadine to Broaden its Single Strategy Offerings with the Engadine...
TeleTrader 2023-03-23 Europe opens mostly lower in Fed's call aftermath
TeleTrader 2022-12-01 Europe opens higher with Fed, data in focus
TeleTrader 2022-09-20 Europe closes with losses on economic uncertainty
TeleTrader 2022-09-20 European stocks turn negative ahead of Fed meeting
GlobeNewswire 2022-03-09 iOnctura to Present Preclinical Data on its Clinical Stage Autotaxin Inhibitor, IOA-289, at AACR
GlobeNewswire 2021-12-09 iOnctura Shows No Dose-limiting Toxicity and Reduced T-regs in Solid Tumor Study of PI3Kδ Inhibitor ...
GlobeNewswire 2021-12-09 iOnctura Presents Positive Clinical Data At ESMO-IO Supporting Advancement of IOA-289, a Novel Autot...
GlobeNewswire 2021-11-24 Futu Announces Third Quarter 2021 Unaudited Financial Results
GlobeNewswire 2021-11-23 iOnctura to Share Clinical and Preclinical Data on IOA-244 and IOA-289 at ESMO-IO in December
GlobeNewswire 2021-11-12 iOnctura Presents Compelling Preclinical Data on its Clinical Stage Autotaxin Inhibitor IOA-289 at S...
GlobeNewswire 2021-11-08 iOnctura Clinical Expansion Positions Lead PI3Kδ Inhibitor IOA-244 for Potential Registration Studie...
GlobeNewswire 2021-11-02 iOnctura to Share Preclinical Data on IOA-289 at SITC in November
GlobeNewswire 2021-10-07 Sentieo Expands Across EMEA; Doubles Staff in London to Support Growth
GlobeNewswire 2021-08-05 iOnctura Strengthens Management With Appointment of Sean A. MacDonald as Chief Business Officer